Psagot Value Holdings’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-20
| Closed | -$1K | – | 565 |
|
|
2023
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 492 |
|
|
2023
Q2 | $2K | Buy |
+20
| New | +$1.59K | ﹤0.01% | 450 |
|
|
2022
Q1 | – | Sell |
-85
| Closed | -$6K | – | 366 |
|
|
2021
Q4 | $6K | Sell |
85
-500
| -85% | -$34.4K | ﹤0.01% | 325 |
|
|
2021
Q3 | $41K | Hold |
585
| – | – | 0.01% | 336 |
|
|
2021
Q2 | $40K | Hold |
585
| – | – | ﹤0.01% | 365 |
|
|
2021
Q1 | $38K | Sell |
585
-250
| -30% | -$16.1K | ﹤0.01% | 324 |
|
|
2020
Q4 | $49K | Sell |
835
-5,682
| -87% | -$343K | ﹤0.01% | 298 |
|
|
2020
Q3 | $412K | Sell |
6,517
-21,258
| -77% | -$1.47M | 0.01% | 218 |
|
|
2020
Q2 | $2.14M | Sell |
27,775
-129,691
| -82% | -$9.94M | 0.06% | 113 |
|
|
2020
Q1 | $11.8M | Sell |
157,466
-222,027
| -59% | -$15.3M | 0.48% | 51 |
|
|
2019
Q4 | $24.7M | Sell |
379,493
-13,691
| -3% | -$892K | 0.83% | 31 |
|
|
2019
Q3 | $24.9M | Sell |
393,184
-1,442
| -0.4% | -$94.3K | 1.02% | 29 |
|
|
2019
Q2 | $26.7M | Sell |
394,626
-15,995
| -4% | -$1.05M | 1.09% | 29 |
|
|
2019
Q1 | $26.7M | Buy |
410,621
+214,545
| +109% | +$14.3M | 1.13% | 23 |
|
|
2018
Q4 | $12.3M | Sell |
196,076
-4,575
| -2% | -$320K | 0.56% | 44 |
|
|
2018
Q3 | $15.5M | Sell |
200,651
-118,447
| -37% | -$8.95M | 0.69% | 41 |
|
|
2018
Q2 | $22.6M | Buy |
319,098
+110,893
| +53% | +$7.83M | 1.05% | 29 |
|
|
2018
Q1 | $15.7M | Sell |
208,205
-78,263
| -27% | -$6.22M | 0.68% | 41 |
|
|
2017
Q4 | $20.5M | Buy |
286,468
+168,691
| +143% | +$12.8M | 0.89% | 33 |
|
|
2017
Q3 | $9.54M | Buy |
117,777
+2,460
| +2% | +$188K | 0.4% | 47 |
|
|
2017
Q2 | $8.16M | Sell |
115,317
-5,036
| -4% | -$335K | 0.35% | 53 |
|
|
2017
Q1 | $8.17M | Buy |
120,353
+19,126
| +19% | +$1.34M | 0.34% | 50 |
|
|
2016
Q4 | $7.25M | Buy |
101,227
+45,216
| +81% | +$3.36M | 0.31% | 53 |
|
|
2016
Q3 | $4.43M | Sell |
56,011
-1,447
| -3% | -$118K | 0.19% | 72 |
|
|
2016
Q2 | $4.79M | Sell |
57,458
-127,666
| -69% | -$11.3M | 0.21% | 67 |
|
|
2016
Q1 | $17M | Sell |
185,124
-3,320
| -2% | -$299K | 0.71% | 37 |
|
|
2015
Q4 | $19.1M | Buy |
188,444
+7,668
| +4% | +$798K | 0.68% | 36 |
|
|
2015
Q3 | $17.8M | Buy |
180,776
+15,465
| +9% | +$1.72M | 0.64% | 36 |
|
|
2015
Q2 | $19.4M | Sell |
165,311
-8,517
| -5% | -$931K | 0.61% | 41 |
|
|
2015
Q1 | $17.1M | Buy |
173,828
+4,402
| +3% | +$447K | 0.54% | 47 |
|
|
2014
Q4 | $16M | Buy |
169,426
+30,134
| +22% | +$3.12M | 0.54% | 47 |
|
|
2014
Q3 | $14.8M | Sell |
139,292
-31,726
| -19% | -$3.11M | 0.5% | 51 |
|
|
2014
Q2 | $14.2M | Buy |
+171,018
| New | +$13.3M | 0.47% | 46 |
|
Other funds holding GILD
Psagot Value Holdings's GILD Position: Q4 2023 in Review
Psagot Value Holdings sold out of Gilead Sciences (GILD) in Q4 2023, closing a stake of 20 shares — an estimated $1K sold.
Psagot Value Holdings first reported a position in GILD in Q2 2014 and held it in 33 quarters. The position peaked at $26.7M in Q1 2019. 1,775 funds tracked by Wall St. Rank hold GILD as of Q4 2023.
- Psagot Value Holdings reported no remaining Gilead Sciences position as of Q4 2023 after selling out during the quarter.
- Psagot Value Holdings sold 20 Gilead Sciences shares in Q4 2023, an estimated $1K.
- Psagot Value Holdings first reported a position in Gilead Sciences in Q2 2014 and held it in 33 quarters.
- Psagot Value Holdings's Gilead Sciences position peaked at $26.7M in Q1 2019.
- 1,775 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2023.
Based on Psagot Value Holdings's 13F filing for Q4 2023, filed 8 Feb 2024.